Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH, COVAIL Study Group

Open source

DOI: 10.1038/s41591-023-02503-4
Published: 2023 Sep
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-023-02503-4,
  title = {Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.},
  author = {Branche AR and Rouphael NG and Diemert DJ and Falsey AR and Losada C and Baden LR and Frey SE and Whitaker JA and Little SJ and Anderson EJ and Walter EB and Novak RM and Rupp R and Jackson LA and Babu TM and Kottkamp AC and Luetkemeyer AF and Immergluck LC and Presti RM and Bäcker M and Winokur PL and Mahgoub SM and Goepfert PA and Fusco DN and Malkin E and Bethony JM and Walsh EE and Graciaa DS and Samaha H and Sherman AC and Walsh SR and Abate G and Oikonomopoulou Z and El Sahly HM and Martin TCS and Kamidani S and Smith MJ and Ladner BG and Porterfield L and Dunstan M and Wald A and Davis T and Atmar RL and Mulligan MJ and Lyke KE and Posavad CM and Meagher MA and Stephens DS and Neuzil KM and Abebe K and Hill H and Albert J and Telu K and Mu J and Lewis TC and Giebeig LA and Eaton A and Netzl A and Wilks SH and Türeli S and Makhene M and Crandon S and Montefiori DC and Makowski M and Smith DJ and Nayak SU and Roberts PC and Beigel JH and COVAIL Study Group},
  year = {2023},
  journal = {Nature medicine},
  doi = {10.1038/s41591-023-02503-4},
  url = {https://doi.org/10.1038/s41591-023-02503-4}
}

RIS

TY  - JOUR
TI  - Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
AU  - Branche AR
AU  - Rouphael NG
AU  - Diemert DJ
AU  - Falsey AR
AU  - Losada C
AU  - Baden LR
AU  - Frey SE
AU  - Whitaker JA
AU  - Little SJ
AU  - Anderson EJ
AU  - Walter EB
AU  - Novak RM
AU  - Rupp R
AU  - Jackson LA
AU  - Babu TM
AU  - Kottkamp AC
AU  - Luetkemeyer AF
AU  - Immergluck LC
AU  - Presti RM
AU  - Bäcker M
AU  - Winokur PL
AU  - Mahgoub SM
AU  - Goepfert PA
AU  - Fusco DN
AU  - Malkin E
AU  - Bethony JM
AU  - Walsh EE
AU  - Graciaa DS
AU  - Samaha H
AU  - Sherman AC
AU  - Walsh SR
AU  - Abate G
AU  - Oikonomopoulou Z
AU  - El Sahly HM
AU  - Martin TCS
AU  - Kamidani S
AU  - Smith MJ
AU  - Ladner BG
AU  - Porterfield L
AU  - Dunstan M
AU  - Wald A
AU  - Davis T
AU  - Atmar RL
AU  - Mulligan MJ
AU  - Lyke KE
AU  - Posavad CM
AU  - Meagher MA
AU  - Stephens DS
AU  - Neuzil KM
AU  - Abebe K
AU  - Hill H
AU  - Albert J
AU  - Telu K
AU  - Mu J
AU  - Lewis TC
AU  - Giebeig LA
AU  - Eaton A
AU  - Netzl A
AU  - Wilks SH
AU  - Türeli S
AU  - Makhene M
AU  - Crandon S
AU  - Montefiori DC
AU  - Makowski M
AU  - Smith DJ
AU  - Nayak SU
AU  - Roberts PC
AU  - Beigel JH
AU  - COVAIL Study Group
PY  - 2023
JO  - Nature medicine
DO  - 10.1038/s41591-023-02503-4
UR  - https://doi.org/10.1038/s41591-023-02503-4
ER  -

APA

AR, B., NG, R., DJ, D., AR, F., C, L., LR, B., SE, F., JA, W., SJ, L., EJ, A., EB, W., RM, N., R, R., LA, J., TM, B., AC, K., AF, L., LC, I., RM, P., M, B., PL, W., SM, M., PA, G., DN, F., E, M., JM, B., EE, W., DS, G., H, S., AC, S., SR, W., G, A., Z, O., HM, E. S., TCS, M., S, K., MJ, S., BG, L., L, P., M, D., A, W., T, D., RL, A., MJ, M., KE, L., CM, P., MA, M., DS, S., KM, N., K, A., H, H., J, A., K, T., J, M., TC, L., LA, G., A, E., A, N., SH, W., S, T., M, M., S, C., DC, M., M, M., DJ, S., SU, N., PC, R., JH, B., & Group, C. S. (2023). Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.. Nature medicine. https://doi.org/10.1038/s41591-023-02503-4

Source records

pubmed · retrieved 2026-09-27T08:17:44.369Z